Note: Ingredients listed on restricted chemical lists
EC/CAS
265-157-1/64742-54-7
Name of the chemical
Distillates (petroleum), hydrotreated heavy paraffinic
Concentration
≥25 - ≤50
EC/CAS
270-128-1/68411-46-1
Name of the chemical
benzenamine, N-phenyl-, reaction products with 2,4,4-trimethylpentene (BPTMP)
Concentration
<1
EC/CAS
204-112-2/115-86-6
Name of the chemical
Triphenylphosphate
Concentration
<1
General Information
Version
2.01
Revision date
2025-08-26
Product name
MOBIL DTE 832
supplier name
Petrocal
Emergency telephone
+44 20 3885 0382, +1-703-527-3887
Icons in SDS
Company Information
company name
PETROPOL S.A
e-mail address of the competent person responsible for the Safety Data Sheet
SDS-DS@exxonmobil.com
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
EUH210 - Safety data sheet available on request. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
None.
2.3 Other hazards
Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a for PBT or vPvB according vPvB. to Regulation (EC) No.
Other hazards which do not result in classification
None known. Nota This material should not be used for any other purpose than the intended use in Section 1 without expert advice. Health studies have shown that chemical exposure may cause potential human health risks which may vary from person to person.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 11 for more detailed information on health effects and symptoms.
